MDHearing Neo XS vs Sony CRE-C20
Side-by-side HearAdvisor lab results with SoundGrades, expert pick badges, and the same visualizations we use in product reviews.

MDHearing Neo XS
The MDHearing Neo XS is a budget-priced OTC hearing aid in the invisible-in-ear style, available for $397. In HearAdvisor lab testing, it earned a C grade with a SoundScore of 2.9/5, ranking #63 of 65 OTC hearing aids tested. Performance results reveal a mixed profile. The Neo XS shows strength in own-voice comfort, scoring 3.2/5—0.69 points above the category average—meaning wearers may experience less of the "boomy" quality that can accompany hearing aid use. Feedback handling is excellent at 5.0/5, sitting 0.46 points above average, so users should experience stable performance without whistling during typical wear. However, speech clarity is a significant limitation. Speech in quiet scores just 1.0/5, falling 1.77 points below the OTC category average. Speech in noise also scores 1.0/5, 0.48 points below average. Music streaming scored 0.0/5, which is 1.92 points below the category average—this device is not suited for audio entertainment. At this price point, several alternatives offer notably stronger performance. The Elehear Beyond (4.36/5), Apple AirPods Pro 2 (4.06/5), and Zepp Clarity Omni (3.88/5) all deliver better overall sound quality in the same price range. The Neo XS may appeal to those prioritizing own-voice comfort and feedback stability over speech intelligibility, but most users seeking meaningful hearing benefit should consider higher-scoring options.

Sony CRE-C20
The Sony CRE-C20 is an invisible-in-ear OTC hearing aid priced at $999, earning a B grade with a SoundScore of 3.6/5 in our lab testing. This mid-priced device offers a discreet form factor with rechargeable batteries, positioning it in the upper tier of the OTC market. In our testing, the CRE-C20 demonstrates notable strengths in speech clarity. Speech in quiet scores 4.1/5—a strong result that sits 1.33 points above the OTC category average. Speech in noise performance reaches 2.7/5, which is 1.24 points above the category average, though only mixed in absolute terms. Own voice comfort scores 2.9/5, slightly above average for the category at +0.39 points. The device shows significant limitations in other areas. Music streaming scored 0.0/5, falling 1.92 points below the category average—this invisible-in-ear design does not support audio streaming functionality. Feedback handling registers at 3.9/5, which is solid in absolute terms, though 0.64 points below the category average of 4.54/5. The CRE-C20 demonstrates meaningful improvement with proper adjustment. The normalized Initial Score of 3.4/5 improves to 4.2/5 when tuned, suggesting users who invest time in optimization will see better results. Within its price range, alternatives like the Sony CRE-E10 (4.69/5) and Lexie B2 Plus (4.43/5) score higher overall. The CRE-C20 is best suited for users prioritizing discretion and speech clarity who don't need music streaming capabilities.
Performance metrics
Scale 1-5 (Tuned)
Lab metric by fit
Scale 1-5 (Tuned)
Speech level
Adjust input dB (Tuned)
Amplification (REIG)
Insertion gain at 65 dB (Tuned)
Fitting configuration for tuned fit